17.21% of Acer Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Acer Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2023	Tudor Investment Corp Et Al	927,041	$0.76M	0.0%	N/A	3.790%
8/15/2023	Hudson Bay Capital Management LP	274,300	$0.25M	0.0%	N/A	1.171%
8/11/2023	BlackRock Inc.	76,772	$71K	0.0%	-25.4%	0.328%
8/3/2023	Hunter Associates Investment Management LLC	60,000	$55K	0.0%	+215.8%	0.256%
5/19/2023	Anson Funds Management LP	129,795	$98K	0.0%	-22.7%	0.554%
5/16/2023	Armistice Capital LLC	2,204,694	$1.67M	0.0%	N/A	9.413%
5/15/2023	Anson Funds Management LP	129,795	$98K	0.0%	-22.7%	0.554%
5/12/2023	Renaissance Technologies LLC	111,800	$85K	0.0%	+91.1%	0.477%
5/12/2023	BlackRock Inc.	102,972	$78K	0.0%	-13.5%	0.440%
2/15/2023	Virtu Financial LLC	10,557	$26K	0.0%	-38.5%	0.066%
2/15/2023	Meridian Wealth Management LLC	71,750	$0.18M	0.0%	N/A	0.450%
2/15/2023	Nantahala Capital Management LLC	1,226,191	$3.08M	0.2%	+76.0%	7.693%
2/13/2023	Renaissance Technologies LLC	58,500	$0.15M	0.0%	-13.5%	0.367%
2/13/2023	Geode Capital Management LLC	96,330	$0.24M	0.0%	+6.1%	0.604%
2/13/2023	Knott David M Jr	140,000	$0.35M	0.1%	N/A	0.878%
2/10/2023	SVB Wealth LLC	11,500	$29K	0.0%	N/A	0.072%
11/10/2022	Nantahala Capital Management LLC	696,538	$0.97M	0.1%	-6.0%	4.369%
8/15/2022	Nantahala Capital Management LLC	741,010	$0.93M	0.0%	-4.7%	4.840%
8/13/2022	Renaissance Technologies LLC	69,700	$88K	0.0%	+216.8%	0.455%
8/5/2022	Copperwynd Financial LLC	23,255	$29K	0.0%	N/A	0.152%
5/13/2022	Nantahala Capital Management LLC	777,820	$2.26M	0.1%	-13.7%	5.080%
5/13/2022	Vanguard Group Inc.	278,215	$0.81M	0.0%	+55.5%	1.817%
8/16/2021	State Street Corp	24,965	$71K	0.0%	N/A	0.174%
8/13/2021	Northern Trust Corp	19,672	$57K	0.0%	-17.9%	0.137%
8/13/2021	Geode Capital Management LLC	57,609	$0.16M	0.0%	+38.8%	0.403%
8/13/2021	Vanguard Group Inc.	179,143	$0.51M	0.0%	+6.6%	1.252%
8/12/2021	XTX Topco Ltd	18,770	$54K	0.0%	N/A	0.131%
8/12/2021	Dimensional Fund Advisors LP	14,665	$42K	0.0%	-31.1%	0.102%
5/19/2021	Virtu Financial LLC	17,646	$55K	0.0%	N/A	0.123%
5/19/2021	Squarepoint Ops LLC	75,014	$0.23M	0.0%	N/A	0.524%
5/14/2021	Nantahala Capital Management LLC	934,755	$2.91M	0.1%	-5.6%	6.532%
5/14/2021	Dimensional Fund Advisors LP	21,293	$66K	0.0%	N/A	0.149%
2/12/2021	Federated Hermes Inc.	114,091	$0.30M	0.0%	-3.0%	0.929%
2/10/2021	HighPoint Advisor Group LLC	29,205	$0.11M	0.0%	N/A	0.238%
11/16/2020	Worth Venture Partners LLC	250,518	$0.72M	0.6%	+57.8%	2.039%
11/12/2020	Federated Hermes Inc.	117,673	$0.34M	0.0%	-19.5%	0.988%
11/10/2020	State Street Corp	12,849	$37K	0.0%	-25.6%	0.108%
11/6/2020	BlackRock Inc.	93,638	$0.27M	0.0%	-43.9%	0.786%
11/6/2020	GSA Capital Partners LLP	82,421	$0.24M	0.0%	N/A	0.692%
9/10/2020	Two Sigma Securities LLC	16,984	$58K	0.0%	N/A	0.143%
8/17/2020	Jane Street Group LLC	18,574	$64K	0.0%	N/A	0.181%
8/14/2020	Worth Venture Partners LLC	158,787	$0.54M	0.3%	N/A	1.549%
8/13/2020	Federated Hermes Inc.	146,097	$0.50M	0.0%	+62.7%	1.425%
8/12/2020	Goldman Sachs Group Inc.	40,312	$0.14M	0.0%	-16.1%	0.393%
8/12/2020	Bank of New York Mellon Corp	13,726	$47K	0.0%	-36.1%	0.134%
6/19/2020	State Street Corp	136,735	$0.27M	0.0%	+22.5%	1.334%
5/13/2020	Parametric Portfolio Associates LLC	71,196	$0.14M	0.0%	-26.8%	0.705%
5/13/2020	Federated Hermes Inc.	89,770	$0.18M	0.0%	+39.0%	0.889%
5/11/2020	State Street Corp	136,735	$0.27M	0.0%	+22.5%	1.354%
5/11/2020	WINTON GROUP Ltd	16,195	$32K	0.0%	-33.8%	0.160%
5/6/2020	Bank of New York Mellon Corp	21,479	$43K	0.0%	+99.7%	0.213%
2/14/2020	J. Goldman & Co LP	73,510	$0.30M	0.0%	-51.9%	0.728%
2/14/2020	Goldman Sachs Group Inc.	50,982	$0.20M	0.0%	-50.1%	0.505%
2/14/2020	UBS Group AG	9,180	$37K	0.0%	+139.7%	0.091%
2/14/2020	CWS Financial Advisors LLC	10,000	$40K	0.0%	N/A	0.099%
2/10/2020	Barclays PLC	98,156	$0.39M	0.0%	+2.6%	0.972%
2/10/2020	Bank of Montreal Can	13,870	$56K	0.0%	-40.1%	0.137%
2/6/2020	State Street Corp	111,579	$0.45M	0.0%	-25.8%	1.105%
11/27/2019	Millennium Management LLC	15,304	$48K	0.0%	N/A	0.152%
11/27/2019	Barclays PLC	95,654	$0.31M	0.0%	+105.1%	0.947%
11/27/2019	State Street Corp	150,466	$0.48M	0.0%	+49.4%	1.491%
8/15/2019	Jane Street Group LLC	12,484	$49K	0.0%	N/A	0.124%
8/14/2019	Citadel Advisors LLC	17,078	$67K	0.0%	N/A	0.169%
8/14/2019	Vanguard Group Inc.	277,963	$1.08M	0.0%	+5.4%	2.756%
8/13/2019	BlackRock Inc.	331,553	$1.29M	0.0%	+1,560.8%	3.287%
8/13/2019	Northern Trust Corp	48,313	$0.19M	0.0%	+24.4%	0.479%
8/12/2019	Bank of New York Mellon Corp	10,774	$42K	0.0%	N/A	0.107%
8/10/2019	Charles Schwab Investment Management Inc.	11,934	$47K	0.0%	N/A	0.118%
8/7/2019	JPMorgan Chase & Co.	21,268	$73K	0.0%	+37.3%	0.211%
8/1/2019	Wedbush Securities Inc.	24,055	$94K	0.0%	N/A	0.238%
6/20/2019	Sphera Funds Management LTD.	50,000	$1.22M	0.1%	N/A	0.496%
5/8/2019	Laurion Capital Management LP	10,400	$0.25M	0.0%	N/A	0.103%
4/29/2019	SG Americas Securities LLC	4,136	$0.10M	0.0%	N/A	0.041%
4/4/2019	Tibra Equities Europe Ltd	12,232	$0.30M	0.0%	N/A	0.121%
2/14/2019	Nantahala Capital Management LLC	903,455	$18.18M	0.6%	+30.7%	9.296%
2/14/2019	Barclays PLC	24,800	$0.50M	0.0%	N/A	0.255%
2/14/2019	venBio Select Advisor LLC	150,000	$3.02M	0.2%	-46.4%	1.543%
2/13/2019	Geode Capital Management LLC	35,736	$0.72M	0.0%	+13.7%	0.368%
2/12/2019	Northern Trust Corp	33,572	$0.68M	0.0%	+5.7%	0.345%
2/8/2019	BlackRock Inc.	9,908	$0.20M	0.0%	-6.4%	0.102%
1/31/2019	Fosun International Ltd	15,700	$0.29M	0.0%	N/A	0.162%
1/30/2019	First Manhattan Co.	13,000	$0.26M	0.0%	+44.4%	0.134%
1/22/2019	Bank of Montreal Can	3,210	$64K	0.0%	+100.0%	0.033%
12/13/2018	Vanguard Group Inc	244,033	$7.53M	0.0%	+1,898.5%	2.511%
11/23/2018	Vanguard Group Inc.	244,033	$7.53M	0.0%	+1,898.5%	2.511%
11/13/2018	Renaissance Technologies LLC	11,235	$0.35M	0.0%	N/A	0.116%
11/13/2018	Vivo Capital LLC	565,579	$17.44M	1.8%	N/A	5.819%
11/13/2018	Monashee Investment Management LLC	11,364	$0.35M	0.1%	N/A	0.117%
11/9/2018	BlackRock Inc.	10,591	$0.33M	0.0%	+36.0%	0.109%
11/8/2018	EAM Investors LLC	21,773	$0.67M	0.1%	N/A	0.224%
11/8/2018	Heartland Advisors Inc.	210,000	$6.48M	0.4%	+36.4%	2.160%
11/7/2018	JPMorgan Chase & Co.	8,704	$0.27M	0.0%	+19,242.2%	0.090%
10/31/2018	Emerald Mutual Fund Advisers Trust	125,000	$3.86M	0.1%	N/A	1.286%
10/15/2018	First Manhattan Co.	9,000	$0.28M	0.0%	+80.0%	0.093%
8/15/2018	Acuta Capital Partners LLC	109,270	$2.36M	0.4%	N/A	1.124%
8/9/2018	BlackRock Inc.	7,786	$0.17M	0.0%	+2,015.8%	0.104%
8/2/2018	Heartland Advisors Inc.	154,000	$3.33M	0.2%	+177.0%	2.053%
5/10/2018	Heartland Advisors Inc.	55,600	$1.07M	0.1%	N/A	0.741%
5/8/2018	Neuberger Berman Group LLC	20,000	$0.39M	0.0%	N/A	0.267%
2/16/2018	J. Goldman & Co LP	108,000	$1.50M	0.1%	N/A	1.465%

Data available starting January 2016

Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. The company's pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-801 for the treatment of induced Vasomotor Symptoms, post-traumatic stress disorder, and prostate cancer; and OLPRUVA, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease. It has a license agreement with Sanofi to acquire worldwide rights to Osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist; an option agreement with Relief for the development, regulatory approval, and commercialization of OLPRUVA; and an agreement with Emory University to acquire the worldwide intellectual property rights to a family of patents and patent applications related to the use of neurokinin receptor antagonists in managing conditioned fear and treating anxiety disorders, including post-traumatic stress disorder. The company was incorporated in 1991 and is headquartered in Newton, Massachusetts.

Today's Range

Now: $0.66

$0.66

$0.85

50 Day Range

MA: $0.78

$0.66

$0.90

52 Week Range

Now: $0.66

$0.55

$4.56

Volume

574,600 shs

Average Volume

261,707 shs

Market Capitalization

$16.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.44

Who are the company insiders with the largest holdings of Acer Therapeutics?: Acer Therapeutics' top insider shareholders include:
Chris Schelling (CEO)
Steve Aselage (Director)
Learn More about top insider investors at Acer Therapeutics.
Who are the major institutional investors of Acer Therapeutics?: Acer Therapeutics' top institutional shareholders include:
Tudor Investment Corp Et Al — 3.79%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Acer Therapeutics stock.
Which major investors are buying Acer Therapeutics stock?: Within the last quarter, ACER stock was purchased by institutional investors including:
Tudor Investment Corp Et Al
In the last year, these company insiders have bought Acer Therapeutics stock:
Chris Schelling (CEO)
Steve Aselage (Director)
Learn More investors buying Acer Therapeutics stock.

All the trading advice you’ve ever received boils down to this

From DTI Trader | Ad

Drop everything and learn about the Income Calendar now.

ACER Insider Trading

Acer Therapeutics Insider Trading History Chart

Acer Therapeutics Share Price & Price History

Acer Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Acer Therapeutics (NASDAQ:ACER)